# Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer

> **NCT01462604** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 27 (actual)

## Conditions studied

- Cancer

## Interventions

- **OTHER:** non-drug intervention educational programme

## Key facts

- **NCT ID:** NCT01462604
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11-23
- **Primary completion:** 2013-01-01
- **Final completion:** 2013-01-24
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2018-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01462604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01462604, "Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01462604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*